January 15, 2010
Out of the millions of Tylenol tablets that are taken daily it only took 70 to get Johnson and Johnson (JNJ) into a world of trouble with the FDA today. JNJ, which was trading down $1.00 as of 1:48PM, was criticized for not responding to 70 customer complaints in an efficient manner. So does this earth shattering story mean that you should dump your JNJ shares? No of course not... well I guess maybe if you were one of those 70 people that got sick off the product. All kidding aside, this does bring up a great fundamental point of investing. No matter how much analysis you do, you will never be able to predict the future.
(This article contains the current opinions of the author but not necessarily those of Brighton Securities Corp. The author's opinions are subject to change without notice. This blog post is for informational purposes only. Forecasts, estimates, and certain information contained herein should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. References to specific securities and their issuers are for illustrative purposes only and are not intended and should not be interpreted as recommendations to purchase or sell such securities).